Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment
作者： Aude Collignon , Anne Wanquet , Elsa Maitre , Edouard Cornet , Xavier Troussard
DOI: 10.1007/S11912-017-0581-X
关键词: Medicine 、 Immunology 、 Prolymphocytic leukemia 、 Lymphoid neoplasms 、 Alemtuzumab 、 Transplantation 、 Leukemia 、 Internal medicine 、 Oncology
摘要: Purpose of Review We aimed to produce a comprehensive update on clinical and biological data regarding two rare lymphoid neoplasms, B T prolymphocytic leukemias, assess therapeutic management in the light new molecular insights advent targeted therapies.
springer.com
sci-hub.se 参考文章(98)
Daniela Lens, Pierre J.J.C. De Schouwer, Rifat A. Hamoudi, Munah Abdul-Rauf, Nahla Farahat, Estella Matutes, Tim Crook, Martin J.S. Dyer, Daniel Catovsky, p53 abnormalities in B-cell prolymphocytic leukemia. Blood. ,vol. 89, pp. 2015- 2023 ,(1997) , 10.1182/BLOOD.V89.6.2015
E Matutes, V Brito-Babapulle, J Swansbury, J Ellis, R Morilla, C Dearden, A Sempere, D Catovsky, Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. ,vol. 78, pp. 3269- 3274 ,(1991) , 10.1182/BLOOD.V78.12.3269.3269
N Sadamori, T Han, J Minowada, ML Bloom, ES Henderson, AA Sandberg, Possible specific chromosome change in prolymphocytic leukemia. Blood. ,vol. 62, pp. 729- 736 ,(1983) , 10.1182/BLOOD.V62.4.729.729
Dominique Stoppa-Lyonnet, Jean Soulier, Anthony Laugé, Hélène Dastot, Richard Garand, François Sigaux, Marc-Henri Stern, Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood. ,vol. 91, pp. 3920- 3926 ,(1998) , 10.1182/BLOOD.V91.10.3920
Rekha Chandran, S. K. Gardiner, T. S. Fenske, E. S. Spurgeon, Survival trends in T cell prolymphocytic leukemia: A SEER database analysis. Leukemia & Lymphoma. ,vol. 57, pp. 942- 944 ,(2016) , 10.3109/10428194.2015.1076932
F Pandolfi, G De Rossi, A Ranucci, G Bonomo, D Pasqualetti, M Napolitano, V Manzari, Tac-positive, HTLV-negative, T helper phenotype chronic lymphocytic leukemia cells. Blood. ,vol. 65, pp. 1531- 1537 ,(1985) , 10.1182/BLOOD.V65.6.1531.BLOODJOURNAL6561531
Raymonde Busch, Natali Pflug, Nicole Weit, Anne Westermann, Anna-Maria Fink, Paula Cramer, Nina Reinart, Dirk Winkler, Günter Fingerle-Rowson, Stephan Stilgenbauer, Hartmut Döhner, Gabriele Kandler, Barbara Eichhorst, Michael Hallek, Marco Herling, Georg Hopfinger, Sequential Chemoimmunotherapy of Fludarabine, Mitoxantrone, and Cyclophosphamide Induction Followed by Alemtuzumab Consolidation Is Effective in T-cell Prolymphocytic Leukemia Cancer. ,vol. 119, pp. 2258- 2267 ,(2013) , 10.1002/CNCR.27972
Anke K. Bergmann, Sina Schneppenheim, Marc Seifert, Matthew J. Betts, Andrea Haake, Cristina Lopez, Eva Maria Murga Penas, Inga Vater, Sandrine Jayne, Martin J.S. Dyer, Martin Schrappe, Ulrich Dührsen, Ole Ammerpohl, Robert B. Russell, Ralf Küppers, Jan Dürig, Reiner Siebert, Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia Genes, Chromosomes and Cancer. ,vol. 53, pp. 309- 316 ,(2014) , 10.1002/GCC.22141
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Estella Matutes, Aaron Polliack, T-cell prolymphocytic leukemia: survival improves with alemtuzemab, but stem cell transplant eligibility ‘counts’ even more Leukemia & Lymphoma. ,vol. 57, pp. 746- 747 ,(2016) , 10.3109/10428194.2015.1081195